Effect of dexamethasone therapy on fibronectin and albumin levels in lung secretions of infants with bronchopulmonary dysplasia
- 31 October 1992
- journal article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 121 (4) , 597-607
- https://doi.org/10.1016/s0022-3476(05)81155-2
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Elevation of fibronectin levels in lung secretions of infants with respiratory distress syndrome and development of bronchopulmonary dysplasiaThe Journal of Pediatrics, 1992
- Cell polarity regulates the release of secretory component, the epithelial receptor for polymeric immunoglobulins, from the surface of HT‐29 colon carcinoma cellsJournal of Cellular Physiology, 1991
- Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants: A controlled trialThe Journal of Pediatrics, 1989
- A Controlled Trial of Dexamethasone in Preterm Infants at High Risk for Bronchopulmonary DysplasiaNew England Journal of Medicine, 1989
- Effects of dexamethasone and indomethacin on elastase, α1-proteinase inhibitor, and fibronectin in bronchoalveolar lavage fluid from neonatesThe Journal of Pediatrics, 1988
- Some recent advances in the chemistry and biology of transforming growth factor-beta.The Journal of cell biology, 1987
- Tracheal lavage and plasma fibronectin: Relationship to respiratory distress syndrome and development of bronchopulmonary dysplasiaThe Journal of Pediatrics, 1986
- Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators.Journal of Clinical Investigation, 1986
- Fibronectin: Applications to Clinical MedicineCRC Critical Reviews in Clinical Laboratory Sciences, 1986
- Fibroblast adhesion to fibrinogen and fibrin substrata: Requirement for cold-insoluble globulin (plasma fibronectin)Cell, 1980